Actionable news
All posts from Actionable news
Actionable news in ABT: ABBOTT LABORATORIES,

The Companion Diagnostics (CDx) Market Forecast 2016-2026: Leading Companies, Trends and Developments in the Growing Theranostics Market

NEW YORK, May 11, 2016 /PRNewswire/ -- Report Details
What can be expected from the Companion Diagnostics market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.

Our 192-page report provides 127 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the whole companion diagnostics market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis) and commercial developments.

The report also includes will find revenue forecasts to 2026 for the following submarkets in the companion diagnostics market:
- Theranostics
- Other Companion Diagnostics

Additionally, this report includes a forecast to 2026 for the global in vitro diagnostics market.

The report also includes will find revenue forecasts to 2026 for the following national and regional markets for companion diagnostics:
- US
- Germany
- France
- Italy
- Spain
- UK
- Japan
- China
- India
- Russia
- Brazil
- South Korea

The report provides detailed profiles of key companies operating within the companion diagnostics market:
- F. Hoffmann-La Roche Ltd
- Qiagen N.V.
- Abbott Laboratories
- Agilent Technologies
- Myriad Genetics
- bioMerieux